nodes	percent_of_prediction	percent_of_DWPC	metapath
Selegiline—CYP3A4—bone cancer	0.537	1	CbGaD
Selegiline—CYP2B6—Cisplatin—bone cancer	0.0401	0.255	CbGbCtD
Selegiline—CYP2B6—Doxorubicin—bone cancer	0.0269	0.171	CbGbCtD
Selegiline—CYP2C9—Cisplatin—bone cancer	0.0212	0.135	CbGbCtD
Selegiline—ABCB1—Cisplatin—bone cancer	0.0206	0.131	CbGbCtD
Selegiline—ABCB1—Doxorubicin—bone cancer	0.0138	0.0877	CbGbCtD
Selegiline—ABCB1—Methotrexate—bone cancer	0.0134	0.085	CbGbCtD
Selegiline—CYP2D6—Doxorubicin—bone cancer	0.013	0.0826	CbGbCtD
Selegiline—CYP3A4—Doxorubicin—bone cancer	0.00826	0.0525	CbGbCtD
Selegiline—CYP2E1—Fatty Acid Omega Oxidation—CYP3A4—bone cancer	0.000901	0.0113	CbGpPWpGaD
Selegiline—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.000861	0.0108	CbGpPWpGaD
Selegiline—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.000843	0.0106	CbGpPWpGaD
Selegiline—CYP2B6—Xenobiotics—CYP3A4—bone cancer	0.000769	0.00967	CbGpPWpGaD
Selegiline—CYP2A6—Fluoropyrimidine Activity—DHFR—bone cancer	0.000754	0.00947	CbGpPWpGaD
Selegiline—CYP2E1—Xenobiotics—CYP3A4—bone cancer	0.000753	0.00947	CbGpPWpGaD
Selegiline—CYP2E1—Tamoxifen metabolism—CYP3A4—bone cancer	0.000724	0.00911	CbGpPWpGaD
Selegiline—CYP3A4—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.000724	0.0091	CbGpPWpGaD
Selegiline—CYP2B6—Metapathway biotransformation—CYP4V2—bone cancer	0.000686	0.00862	CbGpPWpGaD
Selegiline—CYP3A4—Drug Induction of Bile Acid Pathway—NR1I2—bone cancer	0.000681	0.00856	CbGpPWpGaD
Selegiline—CYP2E1—Metapathway biotransformation—CYP4V2—bone cancer	0.000672	0.00844	CbGpPWpGaD
Selegiline—MAOB—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000659	0.00828	CbGpPWpGaD
Selegiline—CYP2A6—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	0.000654	0.00823	CbGpPWpGaD
Selegiline—CYP2C8—Xenobiotics—CYP3A4—bone cancer	0.000651	0.00818	CbGpPWpGaD
Selegiline—ABCB1—Drug Induction of Bile Acid Pathway—CYP3A4—bone cancer	0.000646	0.00812	CbGpPWpGaD
Selegiline—CYP2D6—Fatty Acid Omega Oxidation—CYP3A4—bone cancer	0.000639	0.00803	CbGpPWpGaD
Selegiline—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.000635	0.00798	CbGpPWpGaD
Selegiline—CYP2C8—Tamoxifen metabolism—CYP3A4—bone cancer	0.000626	0.00787	CbGpPWpGaD
Selegiline—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.000593	0.00746	CbGpPWpGaD
Selegiline—CYP2C19—Xenobiotics—CYP3A4—bone cancer	0.000581	0.0073	CbGpPWpGaD
Selegiline—CYP2C8—Metapathway biotransformation—CYP4V2—bone cancer	0.000581	0.0073	CbGpPWpGaD
Selegiline—CYP2C19—Tamoxifen metabolism—CYP3A4—bone cancer	0.000559	0.00703	CbGpPWpGaD
Selegiline—CYP1A2—Fatty Acid Omega Oxidation—CYP3A4—bone cancer	0.000541	0.0068	CbGpPWpGaD
Selegiline—CYP2D6—Xenobiotics—CYP3A4—bone cancer	0.000535	0.00672	CbGpPWpGaD
Selegiline—CYP2C9—Xenobiotics—CYP3A4—bone cancer	0.00053	0.00666	CbGpPWpGaD
Selegiline—CYP2B6—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	0.000528	0.00664	CbGpPWpGaD
Selegiline—CYP2C19—Metapathway biotransformation—CYP4V2—bone cancer	0.000518	0.00651	CbGpPWpGaD
Selegiline—CYP2D6—Tamoxifen metabolism—CYP3A4—bone cancer	0.000514	0.00646	CbGpPWpGaD
Selegiline—CYP2C9—Tamoxifen metabolism—CYP3A4—bone cancer	0.00051	0.00641	CbGpPWpGaD
Selegiline—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.000507	0.00637	CbGpPWpGaD
Selegiline—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—PTGS2—bone cancer	0.000505	0.00635	CbGpPWpGaD
Selegiline—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	0.000503	0.00632	CbGpPWpGaD
Selegiline—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	0.000493	0.00619	CbGpPWpGaD
Selegiline—CYP1A2—Estrogen metabolism—CYP3A4—bone cancer	0.000493	0.00619	CbGpPWpGaD
Selegiline—CYP2D6—Metapathway biotransformation—CYP4V2—bone cancer	0.000477	0.00599	CbGpPWpGaD
Selegiline—CYP2C9—Metapathway biotransformation—CYP4V2—bone cancer	0.000473	0.00594	CbGpPWpGaD
Selegiline—CYP1A2—Aflatoxin activation and detoxification—CYP3A4—bone cancer	0.000472	0.00593	CbGpPWpGaD
Selegiline—MAOB—Tryptophan metabolism—MDM2—bone cancer	0.000462	0.00581	CbGpPWpGaD
Selegiline—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—JUN—bone cancer	0.000455	0.00572	CbGpPWpGaD
Selegiline—CYP1A2—Xenobiotics—CYP3A4—bone cancer	0.000453	0.00569	CbGpPWpGaD
Selegiline—CYP1A2—Tamoxifen metabolism—CYP3A4—bone cancer	0.000436	0.00547	CbGpPWpGaD
Selegiline—MAOA—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000413	0.0052	CbGpPWpGaD
Selegiline—CYP1A2—Metapathway biotransformation—CYP4V2—bone cancer	0.000404	0.00508	CbGpPWpGaD
Selegiline—CYP2C19—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	0.000399	0.00502	CbGpPWpGaD
Selegiline—CYP2A6—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000396	0.00498	CbGpPWpGaD
Selegiline—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.000391	0.00492	CbGpPWpGaD
Selegiline—CYP2A6—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000391	0.00491	CbGpPWpGaD
Selegiline—ABCB1—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	0.000389	0.0049	CbGpPWpGaD
Selegiline—CYP2E1—Tryptophan metabolism—CYP3A4—bone cancer	0.000387	0.00486	CbGpPWpGaD
Selegiline—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	0.000371	0.00466	CbGpPWpGaD
Selegiline—CYP2C9—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	0.000364	0.00457	CbGpPWpGaD
Selegiline—MAOB—Biological oxidations—CYP3A4—bone cancer	0.00035	0.0044	CbGpPWpGaD
Selegiline—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	0.000347	0.00436	CbGpPWpGaD
Selegiline—CYP2A6—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000321	0.00403	CbGpPWpGaD
Selegiline—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000319	0.00401	CbGpPWpGaD
Selegiline—CYP2B6—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000315	0.00396	CbGpPWpGaD
Selegiline—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000313	0.00393	CbGpPWpGaD
Selegiline—CYP3A4—Metapathway biotransformation—CYP4V2—bone cancer	0.000312	0.00392	CbGpPWpGaD
Selegiline—CYP2E1—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000309	0.00388	CbGpPWpGaD
Selegiline—MAOB—Biological oxidations—GSTP1—bone cancer	0.000299	0.00376	CbGpPWpGaD
Selegiline—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	0.000296	0.00372	CbGpPWpGaD
Selegiline—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.00027	0.0034	CbGpPWpGaD
Selegiline—CYP2C8—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000267	0.00335	CbGpPWpGaD
Selegiline—CYP2B6—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000259	0.00325	CbGpPWpGaD
Selegiline—CYP1A2—Estrogen Receptor Pathway—JUN—bone cancer	0.000255	0.00321	CbGpPWpGaD
Selegiline—CYP2E1—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000254	0.00319	CbGpPWpGaD
Selegiline—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000241	0.00303	CbGpPWpGaD
Selegiline—CYP2C19—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000238	0.00299	CbGpPWpGaD
Selegiline—CYP1A2—Tryptophan metabolism—CYP3A4—bone cancer	0.000233	0.00292	CbGpPWpGaD
Selegiline—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000222	0.00279	CbGpPWpGaD
Selegiline—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.00022	0.00277	CbGpPWpGaD
Selegiline—MAOA—Biological oxidations—CYP3A4—bone cancer	0.00022	0.00276	CbGpPWpGaD
Selegiline—CYP2C8—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000219	0.00275	CbGpPWpGaD
Selegiline—CYP2D6—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000219	0.00275	CbGpPWpGaD
Selegiline—CYP2C9—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000217	0.00273	CbGpPWpGaD
Selegiline—MAOB—Metabolism—NDUFA12—bone cancer	0.00021	0.00264	CbGpPWpGaD
Selegiline—Hepatitis—Methotrexate—bone cancer	0.000205	0.000907	CcSEcCtD
Selegiline—Sweating—Epirubicin—bone cancer	0.000205	0.000906	CcSEcCtD
Selegiline—Pollakiuria—Doxorubicin—bone cancer	0.000205	0.000906	CcSEcCtD
Selegiline—Haematuria—Epirubicin—bone cancer	0.000204	0.000901	CcSEcCtD
Selegiline—Pharyngitis—Methotrexate—bone cancer	0.000204	0.0009	CcSEcCtD
Selegiline—Urinary tract disorder—Methotrexate—bone cancer	0.000203	0.000895	CcSEcCtD
Selegiline—Photosensitivity reaction—Doxorubicin—bone cancer	0.000203	0.000895	CcSEcCtD
Selegiline—Hepatobiliary disease—Epirubicin—bone cancer	0.000202	0.000894	CcSEcCtD
Selegiline—Weight increased—Doxorubicin—bone cancer	0.000202	0.000892	CcSEcCtD
Selegiline—Epistaxis—Epirubicin—bone cancer	0.000202	0.000891	CcSEcCtD
Selegiline—Urethral disorder—Methotrexate—bone cancer	0.000201	0.000889	CcSEcCtD
Selegiline—Weight decreased—Doxorubicin—bone cancer	0.000201	0.000887	CcSEcCtD
Selegiline—Sinusitis—Epirubicin—bone cancer	0.000201	0.000887	CcSEcCtD
Selegiline—Hyperglycaemia—Doxorubicin—bone cancer	0.0002	0.000885	CcSEcCtD
Selegiline—Pneumonia—Doxorubicin—bone cancer	0.000199	0.000879	CcSEcCtD
Selegiline—Drowsiness—Doxorubicin—bone cancer	0.000198	0.000874	CcSEcCtD
Selegiline—Visual impairment—Methotrexate—bone cancer	0.000198	0.000874	CcSEcCtD
Selegiline—CYP2C19—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000196	0.00246	CbGpPWpGaD
Selegiline—Hypersensitivity—Cisplatin—bone cancer	0.000196	0.000865	CcSEcCtD
Selegiline—Bradycardia—Epirubicin—bone cancer	0.000195	0.000864	CcSEcCtD
Selegiline—Neuropathy peripheral—Doxorubicin—bone cancer	0.000194	0.000857	CcSEcCtD
Selegiline—Stomatitis—Doxorubicin—bone cancer	0.000193	0.000852	CcSEcCtD
Selegiline—Rhinitis—Epirubicin—bone cancer	0.000192	0.00085	CcSEcCtD
Selegiline—Conjunctivitis—Doxorubicin—bone cancer	0.000192	0.00085	CcSEcCtD
Selegiline—Urinary tract infection—Doxorubicin—bone cancer	0.000192	0.00085	CcSEcCtD
Selegiline—Hepatitis—Epirubicin—bone cancer	0.000192	0.000848	CcSEcCtD
Selegiline—Tinnitus—Methotrexate—bone cancer	0.000191	0.000845	CcSEcCtD
Selegiline—Hypoaesthesia—Epirubicin—bone cancer	0.000191	0.000844	CcSEcCtD
Selegiline—Asthenia—Cisplatin—bone cancer	0.000191	0.000842	CcSEcCtD
Selegiline—Pharyngitis—Epirubicin—bone cancer	0.00019	0.000842	CcSEcCtD
Selegiline—Sweating—Doxorubicin—bone cancer	0.00019	0.000838	CcSEcCtD
Selegiline—Urinary tract disorder—Epirubicin—bone cancer	0.00019	0.000838	CcSEcCtD
Selegiline—Oedema peripheral—Epirubicin—bone cancer	0.000189	0.000836	CcSEcCtD
Selegiline—Haematuria—Doxorubicin—bone cancer	0.000189	0.000834	CcSEcCtD
Selegiline—Urethral disorder—Epirubicin—bone cancer	0.000188	0.000832	CcSEcCtD
Selegiline—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000188	0.00236	CbGpPWpGaD
Selegiline—MAOA—Biological oxidations—GSTP1—bone cancer	0.000188	0.00236	CbGpPWpGaD
Selegiline—Hepatobiliary disease—Doxorubicin—bone cancer	0.000187	0.000827	CcSEcCtD
Selegiline—Epistaxis—Doxorubicin—bone cancer	0.000187	0.000825	CcSEcCtD
Selegiline—Angiopathy—Methotrexate—bone cancer	0.000186	0.000822	CcSEcCtD
Selegiline—Sinusitis—Doxorubicin—bone cancer	0.000186	0.00082	CcSEcCtD
Selegiline—CYP1A2—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000186	0.00233	CbGpPWpGaD
Selegiline—Visual impairment—Epirubicin—bone cancer	0.000185	0.000818	CcSEcCtD
Selegiline—Chills—Methotrexate—bone cancer	0.000184	0.000813	CcSEcCtD
Selegiline—Diarrhoea—Cisplatin—bone cancer	0.000182	0.000803	CcSEcCtD
Selegiline—Alopecia—Methotrexate—bone cancer	0.000181	0.000801	CcSEcCtD
Selegiline—Bradycardia—Doxorubicin—bone cancer	0.000181	0.000799	CcSEcCtD
Selegiline—CYP2D6—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.00018	0.00226	CbGpPWpGaD
Selegiline—Mental disorder—Methotrexate—bone cancer	0.00018	0.000794	CcSEcCtD
Selegiline—Tinnitus—Epirubicin—bone cancer	0.000179	0.000791	CcSEcCtD
Selegiline—Malnutrition—Methotrexate—bone cancer	0.000179	0.000789	CcSEcCtD
Selegiline—Erythema—Methotrexate—bone cancer	0.000179	0.000789	CcSEcCtD
Selegiline—CYP2C9—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000178	0.00224	CbGpPWpGaD
Selegiline—Flushing—Epirubicin—bone cancer	0.000178	0.000787	CcSEcCtD
Selegiline—Rhinitis—Doxorubicin—bone cancer	0.000178	0.000787	CcSEcCtD
Selegiline—CYP2E1—Tryptophan metabolism—MDM2—bone cancer	0.000178	0.00223	CbGpPWpGaD
Selegiline—Hepatitis—Doxorubicin—bone cancer	0.000178	0.000785	CcSEcCtD
Selegiline—Hypoaesthesia—Doxorubicin—bone cancer	0.000177	0.000781	CcSEcCtD
Selegiline—Pharyngitis—Doxorubicin—bone cancer	0.000176	0.000779	CcSEcCtD
Selegiline—Urinary tract disorder—Doxorubicin—bone cancer	0.000175	0.000775	CcSEcCtD
Selegiline—Oedema peripheral—Doxorubicin—bone cancer	0.000175	0.000773	CcSEcCtD
Selegiline—Dysgeusia—Methotrexate—bone cancer	0.000175	0.000773	CcSEcCtD
Selegiline—Angiopathy—Epirubicin—bone cancer	0.000174	0.00077	CcSEcCtD
Selegiline—Urethral disorder—Doxorubicin—bone cancer	0.000174	0.000769	CcSEcCtD
Selegiline—MAOB—Metabolism—NT5C3A—bone cancer	0.000174	0.00218	CbGpPWpGaD
Selegiline—Back pain—Methotrexate—bone cancer	0.000173	0.000763	CcSEcCtD
Selegiline—Chills—Epirubicin—bone cancer	0.000172	0.000761	CcSEcCtD
Selegiline—Arrhythmia—Epirubicin—bone cancer	0.000171	0.000758	CcSEcCtD
Selegiline—Visual impairment—Doxorubicin—bone cancer	0.000171	0.000756	CcSEcCtD
Selegiline—CYP2A6—Biological oxidations—CYP3A4—bone cancer	0.00017	0.00214	CbGpPWpGaD
Selegiline—Alopecia—Epirubicin—bone cancer	0.00017	0.00075	CcSEcCtD
Selegiline—Vomiting—Cisplatin—bone cancer	0.000169	0.000746	CcSEcCtD
Selegiline—CYP2A6—Fluoropyrimidine Activity—TP53—bone cancer	0.000168	0.00212	CbGpPWpGaD
Selegiline—Vision blurred—Methotrexate—bone cancer	0.000168	0.000744	CcSEcCtD
Selegiline—Mental disorder—Epirubicin—bone cancer	0.000168	0.000743	CcSEcCtD
Selegiline—Rash—Cisplatin—bone cancer	0.000167	0.00074	CcSEcCtD
Selegiline—Dermatitis—Cisplatin—bone cancer	0.000167	0.000739	CcSEcCtD
Selegiline—Erythema—Epirubicin—bone cancer	0.000167	0.000738	CcSEcCtD
Selegiline—Malnutrition—Epirubicin—bone cancer	0.000167	0.000738	CcSEcCtD
Selegiline—CYP2A6—NRF2 pathway—TGFBR2—bone cancer	0.000166	0.00209	CbGpPWpGaD
Selegiline—CYP2A6—NRF2 pathway—GSTP1—bone cancer	0.000166	0.00209	CbGpPWpGaD
Selegiline—Ill-defined disorder—Methotrexate—bone cancer	0.000166	0.000732	CcSEcCtD
Selegiline—Tinnitus—Doxorubicin—bone cancer	0.000166	0.000732	CcSEcCtD
Selegiline—Anaemia—Methotrexate—bone cancer	0.000165	0.000729	CcSEcCtD
Selegiline—Flushing—Doxorubicin—bone cancer	0.000165	0.000728	CcSEcCtD
Selegiline—Flatulence—Epirubicin—bone cancer	0.000165	0.000728	CcSEcCtD
Selegiline—Tension—Epirubicin—bone cancer	0.000164	0.000725	CcSEcCtD
Selegiline—Dysgeusia—Epirubicin—bone cancer	0.000164	0.000723	CcSEcCtD
Selegiline—Nervousness—Epirubicin—bone cancer	0.000162	0.000717	CcSEcCtD
Selegiline—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—bone cancer	0.000162	0.00203	CbGpPWpGaD
Selegiline—Back pain—Epirubicin—bone cancer	0.000162	0.000714	CcSEcCtD
Selegiline—Angiopathy—Doxorubicin—bone cancer	0.000161	0.000712	CcSEcCtD
Selegiline—Malaise—Methotrexate—bone cancer	0.000161	0.000712	CcSEcCtD
Selegiline—Muscle spasms—Epirubicin—bone cancer	0.000161	0.00071	CcSEcCtD
Selegiline—Vertigo—Methotrexate—bone cancer	0.00016	0.000709	CcSEcCtD
Selegiline—Leukopenia—Methotrexate—bone cancer	0.00016	0.000706	CcSEcCtD
Selegiline—Chills—Doxorubicin—bone cancer	0.000159	0.000704	CcSEcCtD
Selegiline—Arrhythmia—Doxorubicin—bone cancer	0.000159	0.000701	CcSEcCtD
Selegiline—Nausea—Cisplatin—bone cancer	0.000158	0.000697	CcSEcCtD
Selegiline—Vision blurred—Epirubicin—bone cancer	0.000157	0.000696	CcSEcCtD
Selegiline—Alopecia—Doxorubicin—bone cancer	0.000157	0.000694	CcSEcCtD
Selegiline—Cough—Methotrexate—bone cancer	0.000156	0.000689	CcSEcCtD
Selegiline—Mental disorder—Doxorubicin—bone cancer	0.000156	0.000688	CcSEcCtD
Selegiline—Ill-defined disorder—Epirubicin—bone cancer	0.000155	0.000685	CcSEcCtD
Selegiline—Convulsion—Methotrexate—bone cancer	0.000155	0.000684	CcSEcCtD
Selegiline—Malnutrition—Doxorubicin—bone cancer	0.000155	0.000683	CcSEcCtD
Selegiline—Erythema—Doxorubicin—bone cancer	0.000155	0.000683	CcSEcCtD
Selegiline—Anaemia—Epirubicin—bone cancer	0.000154	0.000683	CcSEcCtD
Selegiline—Agitation—Epirubicin—bone cancer	0.000154	0.000679	CcSEcCtD
Selegiline—CYP1A2—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000152	0.00192	CbGpPWpGaD
Selegiline—Flatulence—Doxorubicin—bone cancer	0.000152	0.000673	CcSEcCtD
Selegiline—Myalgia—Methotrexate—bone cancer	0.000152	0.000672	CcSEcCtD
Selegiline—Chest pain—Methotrexate—bone cancer	0.000152	0.000672	CcSEcCtD
Selegiline—Arthralgia—Methotrexate—bone cancer	0.000152	0.000672	CcSEcCtD
Selegiline—Tension—Doxorubicin—bone cancer	0.000152	0.000671	CcSEcCtD
Selegiline—Dysgeusia—Doxorubicin—bone cancer	0.000151	0.000669	CcSEcCtD
Selegiline—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—bone cancer	0.000151	0.000667	CcSEcCtD
Selegiline—Malaise—Epirubicin—bone cancer	0.000151	0.000666	CcSEcCtD
Selegiline—Discomfort—Methotrexate—bone cancer	0.00015	0.000664	CcSEcCtD
Selegiline—Nervousness—Doxorubicin—bone cancer	0.00015	0.000664	CcSEcCtD
Selegiline—Vertigo—Epirubicin—bone cancer	0.00015	0.000663	CcSEcCtD
Selegiline—Syncope—Epirubicin—bone cancer	0.00015	0.000662	CcSEcCtD
Selegiline—Leukopenia—Epirubicin—bone cancer	0.00015	0.000661	CcSEcCtD
Selegiline—Back pain—Doxorubicin—bone cancer	0.00015	0.000661	CcSEcCtD
Selegiline—Muscle spasms—Doxorubicin—bone cancer	0.000149	0.000657	CcSEcCtD
Selegiline—Palpitations—Epirubicin—bone cancer	0.000148	0.000653	CcSEcCtD
Selegiline—Confusional state—Methotrexate—bone cancer	0.000147	0.000649	CcSEcCtD
Selegiline—Loss of consciousness—Epirubicin—bone cancer	0.000147	0.000649	CcSEcCtD
Selegiline—Cough—Epirubicin—bone cancer	0.000146	0.000644	CcSEcCtD
Selegiline—CYP2A6—Biological oxidations—GSTP1—bone cancer	0.000146	0.00183	CbGpPWpGaD
Selegiline—Vision blurred—Doxorubicin—bone cancer	0.000146	0.000644	CcSEcCtD
Selegiline—Convulsion—Epirubicin—bone cancer	0.000145	0.00064	CcSEcCtD
Selegiline—Infection—Methotrexate—bone cancer	0.000145	0.00064	CcSEcCtD
Selegiline—Hypertension—Epirubicin—bone cancer	0.000144	0.000638	CcSEcCtD
Selegiline—Ill-defined disorder—Doxorubicin—bone cancer	0.000143	0.000634	CcSEcCtD
Selegiline—Nervous system disorder—Methotrexate—bone cancer	0.000143	0.000632	CcSEcCtD
Selegiline—Anaemia—Doxorubicin—bone cancer	0.000143	0.000632	CcSEcCtD
Selegiline—Thrombocytopenia—Methotrexate—bone cancer	0.000143	0.000631	CcSEcCtD
Selegiline—Chest pain—Epirubicin—bone cancer	0.000142	0.000629	CcSEcCtD
Selegiline—Myalgia—Epirubicin—bone cancer	0.000142	0.000629	CcSEcCtD
Selegiline—Arthralgia—Epirubicin—bone cancer	0.000142	0.000629	CcSEcCtD
Selegiline—Agitation—Doxorubicin—bone cancer	0.000142	0.000628	CcSEcCtD
Selegiline—Anxiety—Epirubicin—bone cancer	0.000142	0.000627	CcSEcCtD
Selegiline—Skin disorder—Methotrexate—bone cancer	0.000142	0.000626	CcSEcCtD
Selegiline—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—bone cancer	0.000141	0.000624	CcSEcCtD
Selegiline—Hyperhidrosis—Methotrexate—bone cancer	0.000141	0.000623	CcSEcCtD
Selegiline—Discomfort—Epirubicin—bone cancer	0.000141	0.000621	CcSEcCtD
Selegiline—Malaise—Doxorubicin—bone cancer	0.000139	0.000616	CcSEcCtD
Selegiline—Dry mouth—Epirubicin—bone cancer	0.000139	0.000615	CcSEcCtD
Selegiline—Vertigo—Doxorubicin—bone cancer	0.000139	0.000614	CcSEcCtD
Selegiline—Anorexia—Methotrexate—bone cancer	0.000139	0.000614	CcSEcCtD
Selegiline—Syncope—Doxorubicin—bone cancer	0.000139	0.000613	CcSEcCtD
Selegiline—CYP2C8—Arachidonic acid metabolism—PTGS2—bone cancer	0.000139	0.00174	CbGpPWpGaD
Selegiline—Leukopenia—Doxorubicin—bone cancer	0.000138	0.000612	CcSEcCtD
Selegiline—CYP2B6—Biological oxidations—CYP3A4—bone cancer	0.000138	0.00173	CbGpPWpGaD
Selegiline—Confusional state—Epirubicin—bone cancer	0.000137	0.000608	CcSEcCtD
Selegiline—Palpitations—Doxorubicin—bone cancer	0.000137	0.000604	CcSEcCtD
Selegiline—Oedema—Epirubicin—bone cancer	0.000136	0.000603	CcSEcCtD
Selegiline—Hypotension—Methotrexate—bone cancer	0.000136	0.000602	CcSEcCtD
Selegiline—Loss of consciousness—Doxorubicin—bone cancer	0.000136	0.000601	CcSEcCtD
Selegiline—CYP2B6—Metapathway biotransformation—CYP3A4—bone cancer	0.000136	0.0017	CbGpPWpGaD
Selegiline—Infection—Epirubicin—bone cancer	0.000135	0.000599	CcSEcCtD
Selegiline—Cough—Doxorubicin—bone cancer	0.000135	0.000596	CcSEcCtD
Selegiline—CYP2E1—Biological oxidations—CYP3A4—bone cancer	0.000135	0.00169	CbGpPWpGaD
Selegiline—Shock—Epirubicin—bone cancer	0.000134	0.000593	CcSEcCtD
Selegiline—Convulsion—Doxorubicin—bone cancer	0.000134	0.000592	CcSEcCtD
Selegiline—Nervous system disorder—Epirubicin—bone cancer	0.000134	0.000591	CcSEcCtD
Selegiline—Thrombocytopenia—Epirubicin—bone cancer	0.000134	0.00059	CcSEcCtD
Selegiline—Hypertension—Doxorubicin—bone cancer	0.000133	0.00059	CcSEcCtD
Selegiline—Tachycardia—Epirubicin—bone cancer	0.000133	0.000588	CcSEcCtD
Selegiline—CYP2E1—Metapathway biotransformation—CYP3A4—bone cancer	0.000133	0.00167	CbGpPWpGaD
Selegiline—Musculoskeletal discomfort—Methotrexate—bone cancer	0.000133	0.000587	CcSEcCtD
Selegiline—Skin disorder—Epirubicin—bone cancer	0.000132	0.000585	CcSEcCtD
Selegiline—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—bone cancer	0.000132	0.00166	CbGpPWpGaD
Selegiline—Hyperhidrosis—Epirubicin—bone cancer	0.000132	0.000583	CcSEcCtD
Selegiline—Insomnia—Methotrexate—bone cancer	0.000132	0.000583	CcSEcCtD
Selegiline—Myalgia—Doxorubicin—bone cancer	0.000132	0.000582	CcSEcCtD
Selegiline—Arthralgia—Doxorubicin—bone cancer	0.000132	0.000582	CcSEcCtD
Selegiline—Chest pain—Doxorubicin—bone cancer	0.000132	0.000582	CcSEcCtD
Selegiline—MAOA—Metabolism—NDUFA12—bone cancer	0.000132	0.00165	CbGpPWpGaD
Selegiline—Anxiety—Doxorubicin—bone cancer	0.000131	0.00058	CcSEcCtD
Selegiline—Paraesthesia—Methotrexate—bone cancer	0.000131	0.000578	CcSEcCtD
Selegiline—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—bone cancer	0.000131	0.000578	CcSEcCtD
Selegiline—Discomfort—Doxorubicin—bone cancer	0.00013	0.000575	CcSEcCtD
Selegiline—Anorexia—Epirubicin—bone cancer	0.00013	0.000575	CcSEcCtD
Selegiline—Dyspnoea—Methotrexate—bone cancer	0.00013	0.000574	CcSEcCtD
Selegiline—Somnolence—Methotrexate—bone cancer	0.00013	0.000573	CcSEcCtD
Selegiline—Dry mouth—Doxorubicin—bone cancer	0.000129	0.000569	CcSEcCtD
Selegiline—Dyspepsia—Methotrexate—bone cancer	0.000128	0.000567	CcSEcCtD
Selegiline—Hypotension—Epirubicin—bone cancer	0.000127	0.000563	CcSEcCtD
Selegiline—Confusional state—Doxorubicin—bone cancer	0.000127	0.000562	CcSEcCtD
Selegiline—Decreased appetite—Methotrexate—bone cancer	0.000127	0.00056	CcSEcCtD
Selegiline—Oedema—Doxorubicin—bone cancer	0.000126	0.000558	CcSEcCtD
Selegiline—Gastrointestinal disorder—Methotrexate—bone cancer	0.000126	0.000556	CcSEcCtD
Selegiline—Fatigue—Methotrexate—bone cancer	0.000126	0.000555	CcSEcCtD
Selegiline—CYP1A2—Aryl Hydrocarbon Receptor—RB1—bone cancer	0.000125	0.00158	CbGpPWpGaD
Selegiline—Infection—Doxorubicin—bone cancer	0.000125	0.000554	CcSEcCtD
Selegiline—Pain—Methotrexate—bone cancer	0.000125	0.000551	CcSEcCtD
Selegiline—Musculoskeletal discomfort—Epirubicin—bone cancer	0.000124	0.000549	CcSEcCtD
Selegiline—Shock—Doxorubicin—bone cancer	0.000124	0.000549	CcSEcCtD
Selegiline—Nervous system disorder—Doxorubicin—bone cancer	0.000124	0.000547	CcSEcCtD
Selegiline—CYP2C19—Arachidonic acid metabolism—PTGS2—bone cancer	0.000124	0.00156	CbGpPWpGaD
Selegiline—Thrombocytopenia—Doxorubicin—bone cancer	0.000124	0.000546	CcSEcCtD
Selegiline—Insomnia—Epirubicin—bone cancer	0.000123	0.000545	CcSEcCtD
Selegiline—Tachycardia—Doxorubicin—bone cancer	0.000123	0.000544	CcSEcCtD
Selegiline—Skin disorder—Doxorubicin—bone cancer	0.000123	0.000542	CcSEcCtD
Selegiline—Paraesthesia—Epirubicin—bone cancer	0.000122	0.000541	CcSEcCtD
Selegiline—Hyperhidrosis—Doxorubicin—bone cancer	0.000122	0.000539	CcSEcCtD
Selegiline—Dyspnoea—Epirubicin—bone cancer	0.000122	0.000537	CcSEcCtD
Selegiline—Somnolence—Epirubicin—bone cancer	0.000121	0.000536	CcSEcCtD
Selegiline—Anorexia—Doxorubicin—bone cancer	0.00012	0.000532	CcSEcCtD
Selegiline—Feeling abnormal—Methotrexate—bone cancer	0.00012	0.000531	CcSEcCtD
Selegiline—Dyspepsia—Epirubicin—bone cancer	0.00012	0.000531	CcSEcCtD
Selegiline—Gastrointestinal pain—Methotrexate—bone cancer	0.000119	0.000527	CcSEcCtD
Selegiline—Decreased appetite—Epirubicin—bone cancer	0.000119	0.000524	CcSEcCtD
Selegiline—CYP1A2—Phase II conjugation—GSTP1—bone cancer	0.000118	0.00149	CbGpPWpGaD
Selegiline—Hypotension—Doxorubicin—bone cancer	0.000118	0.000521	CcSEcCtD
Selegiline—Gastrointestinal disorder—Epirubicin—bone cancer	0.000118	0.00052	CcSEcCtD
Selegiline—CYP2B6—Biological oxidations—GSTP1—bone cancer	0.000118	0.00148	CbGpPWpGaD
Selegiline—Fatigue—Epirubicin—bone cancer	0.000118	0.00052	CcSEcCtD
Selegiline—Constipation—Epirubicin—bone cancer	0.000117	0.000515	CcSEcCtD
Selegiline—Pain—Epirubicin—bone cancer	0.000117	0.000515	CcSEcCtD
Selegiline—CYP2C8—Biological oxidations—CYP3A4—bone cancer	0.000116	0.00146	CbGpPWpGaD
Selegiline—CYP2B6—Metapathway biotransformation—GSTP1—bone cancer	0.000116	0.00146	CbGpPWpGaD
Selegiline—Urticaria—Methotrexate—bone cancer	0.000116	0.000512	CcSEcCtD
Selegiline—CYP2E1—Biological oxidations—GSTP1—bone cancer	0.000115	0.00145	CbGpPWpGaD
Selegiline—Abdominal pain—Methotrexate—bone cancer	0.000115	0.000509	CcSEcCtD
Selegiline—Body temperature increased—Methotrexate—bone cancer	0.000115	0.000509	CcSEcCtD
Selegiline—Musculoskeletal discomfort—Doxorubicin—bone cancer	0.000115	0.000508	CcSEcCtD
Selegiline—CYP2C8—Metapathway biotransformation—CYP3A4—bone cancer	0.000115	0.00144	CbGpPWpGaD
Selegiline—Insomnia—Doxorubicin—bone cancer	0.000114	0.000504	CcSEcCtD
Selegiline—CYP2E1—Metapathway biotransformation—GSTP1—bone cancer	0.000114	0.00143	CbGpPWpGaD
Selegiline—Paraesthesia—Doxorubicin—bone cancer	0.000113	0.000501	CcSEcCtD
Selegiline—CYP2C9—Arachidonic acid metabolism—PTGS2—bone cancer	0.000113	0.00142	CbGpPWpGaD
Selegiline—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—bone cancer	0.000112	0.00141	CbGpPWpGaD
Selegiline—Dyspnoea—Doxorubicin—bone cancer	0.000112	0.000497	CcSEcCtD
Selegiline—Feeling abnormal—Epirubicin—bone cancer	0.000112	0.000497	CcSEcCtD
Selegiline—Somnolence—Doxorubicin—bone cancer	0.000112	0.000496	CcSEcCtD
Selegiline—Gastrointestinal pain—Epirubicin—bone cancer	0.000112	0.000493	CcSEcCtD
Selegiline—Dyspepsia—Doxorubicin—bone cancer	0.000111	0.000491	CcSEcCtD
Selegiline—Decreased appetite—Doxorubicin—bone cancer	0.00011	0.000485	CcSEcCtD
Selegiline—MAOA—Metabolism—NT5C3A—bone cancer	0.000109	0.00137	CbGpPWpGaD
Selegiline—Gastrointestinal disorder—Doxorubicin—bone cancer	0.000109	0.000481	CcSEcCtD
Selegiline—Fatigue—Doxorubicin—bone cancer	0.000109	0.000481	CcSEcCtD
Selegiline—Urticaria—Epirubicin—bone cancer	0.000108	0.000479	CcSEcCtD
Selegiline—Constipation—Doxorubicin—bone cancer	0.000108	0.000477	CcSEcCtD
Selegiline—Pain—Doxorubicin—bone cancer	0.000108	0.000477	CcSEcCtD
Selegiline—Body temperature increased—Epirubicin—bone cancer	0.000108	0.000476	CcSEcCtD
Selegiline—Abdominal pain—Epirubicin—bone cancer	0.000108	0.000476	CcSEcCtD
Selegiline—Hypersensitivity—Methotrexate—bone cancer	0.000107	0.000475	CcSEcCtD
Selegiline—CYP1A2—Tryptophan metabolism—MDM2—bone cancer	0.000107	0.00134	CbGpPWpGaD
Selegiline—MAOA—Transmission across Chemical Synapses—BRAF—bone cancer	0.000107	0.00134	CbGpPWpGaD
Selegiline—Asthenia—Methotrexate—bone cancer	0.000105	0.000462	CcSEcCtD
Selegiline—Feeling abnormal—Doxorubicin—bone cancer	0.000104	0.00046	CcSEcCtD
Selegiline—CYP2C19—Biological oxidations—CYP3A4—bone cancer	0.000104	0.00131	CbGpPWpGaD
Selegiline—Gastrointestinal pain—Doxorubicin—bone cancer	0.000103	0.000456	CcSEcCtD
Selegiline—Pruritus—Methotrexate—bone cancer	0.000103	0.000456	CcSEcCtD
Selegiline—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—bone cancer	0.000103	0.0013	CbGpPWpGaD
Selegiline—CYP2C19—Metapathway biotransformation—CYP3A4—bone cancer	0.000102	0.00129	CbGpPWpGaD
Selegiline—ABCB1—Integrated Pancreatic Cancer Pathway—EZH2—bone cancer	0.000102	0.00129	CbGpPWpGaD
Selegiline—CYP2A6—Metabolism—NDUFA12—bone cancer	0.000102	0.00128	CbGpPWpGaD
Selegiline—Hypersensitivity—Epirubicin—bone cancer	0.0001	0.000444	CcSEcCtD
Selegiline—Urticaria—Doxorubicin—bone cancer	0.0001	0.000443	CcSEcCtD
Selegiline—Body temperature increased—Doxorubicin—bone cancer	9.97e-05	0.000441	CcSEcCtD
Selegiline—Abdominal pain—Doxorubicin—bone cancer	9.97e-05	0.000441	CcSEcCtD
Selegiline—Diarrhoea—Methotrexate—bone cancer	9.97e-05	0.000441	CcSEcCtD
Selegiline—CYP2C8—Biological oxidations—GSTP1—bone cancer	9.96e-05	0.00125	CbGpPWpGaD
Selegiline—CYP2C8—Metapathway biotransformation—GSTP1—bone cancer	9.82e-05	0.00123	CbGpPWpGaD
Selegiline—Asthenia—Epirubicin—bone cancer	9.78e-05	0.000432	CcSEcCtD
Selegiline—Pruritus—Epirubicin—bone cancer	9.65e-05	0.000426	CcSEcCtD
Selegiline—CYP1A2—Arachidonic acid metabolism—PTGS2—bone cancer	9.64e-05	0.00121	CbGpPWpGaD
Selegiline—Dizziness—Methotrexate—bone cancer	9.64e-05	0.000426	CcSEcCtD
Selegiline—CYP2D6—Biological oxidations—CYP3A4—bone cancer	9.56e-05	0.0012	CbGpPWpGaD
Selegiline—MAOA—SIDS Susceptibility Pathways—JUN—bone cancer	9.48e-05	0.00119	CbGpPWpGaD
Selegiline—CYP2C9—Biological oxidations—CYP3A4—bone cancer	9.48e-05	0.00119	CbGpPWpGaD
Selegiline—CYP2D6—Metapathway biotransformation—CYP3A4—bone cancer	9.43e-05	0.00118	CbGpPWpGaD
Selegiline—CYP2C9—Metapathway biotransformation—CYP3A4—bone cancer	9.35e-05	0.00117	CbGpPWpGaD
Selegiline—Diarrhoea—Epirubicin—bone cancer	9.33e-05	0.000412	CcSEcCtD
Selegiline—ABCB1—Integrated Pancreatic Cancer Pathway—IL3—bone cancer	9.33e-05	0.00117	CbGpPWpGaD
Selegiline—Hypersensitivity—Doxorubicin—bone cancer	9.3e-05	0.000411	CcSEcCtD
Selegiline—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—bone cancer	9.29e-05	0.00117	CbGpPWpGaD
Selegiline—Vomiting—Methotrexate—bone cancer	9.26e-05	0.000409	CcSEcCtD
Selegiline—ABCB1—Integrated Pancreatic Cancer Pathway—CHEK2—bone cancer	9.2e-05	0.00116	CbGpPWpGaD
Selegiline—Rash—Methotrexate—bone cancer	9.19e-05	0.000406	CcSEcCtD
Selegiline—Dermatitis—Methotrexate—bone cancer	9.18e-05	0.000406	CcSEcCtD
Selegiline—Headache—Methotrexate—bone cancer	9.13e-05	0.000403	CcSEcCtD
Selegiline—Asthenia—Doxorubicin—bone cancer	9.05e-05	0.0004	CcSEcCtD
Selegiline—Dizziness—Epirubicin—bone cancer	9.02e-05	0.000399	CcSEcCtD
Selegiline—MAOA—Transmission across Chemical Synapses—MDM2—bone cancer	8.94e-05	0.00112	CbGpPWpGaD
Selegiline—Pruritus—Doxorubicin—bone cancer	8.93e-05	0.000395	CcSEcCtD
Selegiline—CYP2C19—Biological oxidations—GSTP1—bone cancer	8.89e-05	0.00112	CbGpPWpGaD
Selegiline—CYP2C19—Metapathway biotransformation—GSTP1—bone cancer	8.77e-05	0.0011	CbGpPWpGaD
Selegiline—ABCB1—HIF-1-alpha transcription factor network—JUN—bone cancer	8.72e-05	0.0011	CbGpPWpGaD
Selegiline—Vomiting—Epirubicin—bone cancer	8.67e-05	0.000383	CcSEcCtD
Selegiline—Nausea—Methotrexate—bone cancer	8.65e-05	0.000383	CcSEcCtD
Selegiline—Diarrhoea—Doxorubicin—bone cancer	8.63e-05	0.000382	CcSEcCtD
Selegiline—Rash—Epirubicin—bone cancer	8.6e-05	0.00038	CcSEcCtD
Selegiline—Dermatitis—Epirubicin—bone cancer	8.59e-05	0.00038	CcSEcCtD
Selegiline—Headache—Epirubicin—bone cancer	8.54e-05	0.000378	CcSEcCtD
Selegiline—CYP2A6—Metabolism—NT5C3A—bone cancer	8.47e-05	0.00106	CbGpPWpGaD
Selegiline—Dizziness—Doxorubicin—bone cancer	8.34e-05	0.000369	CcSEcCtD
Selegiline—CYP3A4—Tryptophan metabolism—MDM2—bone cancer	8.25e-05	0.00104	CbGpPWpGaD
Selegiline—CYP2B6—Metabolism—NDUFA12—bone cancer	8.24e-05	0.00104	CbGpPWpGaD
Selegiline—MAOA—Neuronal System—BRAF—bone cancer	8.18e-05	0.00103	CbGpPWpGaD
Selegiline—CYP2D6—Biological oxidations—GSTP1—bone cancer	8.18e-05	0.00103	CbGpPWpGaD
Selegiline—CYP2C9—Biological oxidations—GSTP1—bone cancer	8.1e-05	0.00102	CbGpPWpGaD
Selegiline—Nausea—Epirubicin—bone cancer	8.1e-05	0.000358	CcSEcCtD
Selegiline—CYP1A2—Biological oxidations—CYP3A4—bone cancer	8.1e-05	0.00102	CbGpPWpGaD
Selegiline—CYP2E1—Metabolism—NDUFA12—bone cancer	8.07e-05	0.00101	CbGpPWpGaD
Selegiline—CYP2D6—Metapathway biotransformation—GSTP1—bone cancer	8.06e-05	0.00101	CbGpPWpGaD
Selegiline—Vomiting—Doxorubicin—bone cancer	8.02e-05	0.000355	CcSEcCtD
Selegiline—CYP2C9—Metapathway biotransformation—GSTP1—bone cancer	7.99e-05	0.001	CbGpPWpGaD
Selegiline—CYP1A2—Metapathway biotransformation—CYP3A4—bone cancer	7.99e-05	0.001	CbGpPWpGaD
Selegiline—Rash—Doxorubicin—bone cancer	7.96e-05	0.000352	CcSEcCtD
Selegiline—Dermatitis—Doxorubicin—bone cancer	7.95e-05	0.000351	CcSEcCtD
Selegiline—Headache—Doxorubicin—bone cancer	7.9e-05	0.000349	CcSEcCtD
Selegiline—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—bone cancer	7.8e-05	0.00098	CbGpPWpGaD
Selegiline—ABCB1—Transmembrane transport of small molecules—TUBB4B—bone cancer	7.78e-05	0.000977	CbGpPWpGaD
Selegiline—MAOB—Metabolism—ENO2—bone cancer	7.61e-05	0.000957	CbGpPWpGaD
Selegiline—Nausea—Doxorubicin—bone cancer	7.49e-05	0.000331	CcSEcCtD
Selegiline—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—bone cancer	7.31e-05	0.000918	CbGpPWpGaD
Selegiline—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—bone cancer	7.31e-05	0.000918	CbGpPWpGaD
Selegiline—MAOB—Metabolism—DHFR—bone cancer	7.06e-05	0.000888	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—NDUFA12—bone cancer	6.98e-05	0.000877	CbGpPWpGaD
Selegiline—CYP1A2—Biological oxidations—GSTP1—bone cancer	6.93e-05	0.00087	CbGpPWpGaD
Selegiline—MAOA—Neuronal System—MDM2—bone cancer	6.85e-05	0.000861	CbGpPWpGaD
Selegiline—CYP2B6—Metabolism—NT5C3A—bone cancer	6.83e-05	0.000859	CbGpPWpGaD
Selegiline—CYP1A2—Metapathway biotransformation—GSTP1—bone cancer	6.83e-05	0.000859	CbGpPWpGaD
Selegiline—ABCB1—Transmembrane transport of small molecules—TUBB2A—bone cancer	6.71e-05	0.000844	CbGpPWpGaD
Selegiline—CYP2E1—Metabolism—NT5C3A—bone cancer	6.69e-05	0.000841	CbGpPWpGaD
Selegiline—MAOB—Metabolism—GNA11—bone cancer	6.6e-05	0.00083	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—NDUFA12—bone cancer	6.23e-05	0.000783	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—NDUFA12—bone cancer	6.08e-05	0.000764	CbGpPWpGaD
Selegiline—MAOB—Metabolism—CYP3A4—bone cancer	5.98e-05	0.000752	CbGpPWpGaD
Selegiline—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—bone cancer	5.78e-05	0.000727	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—NT5C3A—bone cancer	5.78e-05	0.000727	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—NDUFA12—bone cancer	5.73e-05	0.00072	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—NDUFA12—bone cancer	5.68e-05	0.000714	CbGpPWpGaD
Selegiline—CYP3A4—Biological oxidations—GSTP1—bone cancer	5.34e-05	0.000672	CbGpPWpGaD
Selegiline—CYP3A4—Metapathway biotransformation—GSTP1—bone cancer	5.27e-05	0.000663	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—NT5C3A—bone cancer	5.16e-05	0.000649	CbGpPWpGaD
Selegiline—MAOB—Metabolism—GSTP1—bone cancer	5.12e-05	0.000643	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—NT5C3A—bone cancer	5.04e-05	0.000633	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—NDUFA12—bone cancer	4.85e-05	0.00061	CbGpPWpGaD
Selegiline—MAOA—Metabolism—ENO2—bone cancer	4.78e-05	0.0006	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—NT5C3A—bone cancer	4.75e-05	0.000597	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—NT5C3A—bone cancer	4.71e-05	0.000592	CbGpPWpGaD
Selegiline—MAOA—Metabolism—DHFR—bone cancer	4.43e-05	0.000557	CbGpPWpGaD
Selegiline—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—bone cancer	4.29e-05	0.000539	CbGpPWpGaD
Selegiline—MAOA—Metabolism—GNA11—bone cancer	4.14e-05	0.000521	CbGpPWpGaD
Selegiline—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—bone cancer	4.13e-05	0.000519	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—NT5C3A—bone cancer	4.02e-05	0.000506	CbGpPWpGaD
Selegiline—MAOA—Metabolism—CYP3A4—bone cancer	3.75e-05	0.000472	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—NDUFA12—bone cancer	3.75e-05	0.000471	CbGpPWpGaD
Selegiline—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—bone cancer	3.73e-05	0.000468	CbGpPWpGaD
Selegiline—CYP2A6—Metabolism—ENO2—bone cancer	3.71e-05	0.000466	CbGpPWpGaD
Selegiline—CYP2A6—Metabolism—DHFR—bone cancer	3.44e-05	0.000432	CbGpPWpGaD
Selegiline—CYP2A6—Metabolism—GNA11—bone cancer	3.22e-05	0.000404	CbGpPWpGaD
Selegiline—MAOA—Metabolism—GSTP1—bone cancer	3.21e-05	0.000404	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—NT5C3A—bone cancer	3.1e-05	0.00039	CbGpPWpGaD
Selegiline—CYP2B6—Metabolism—ENO2—bone cancer	2.99e-05	0.000376	CbGpPWpGaD
Selegiline—CYP2E1—Metabolism—ENO2—bone cancer	2.93e-05	0.000368	CbGpPWpGaD
Selegiline—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—bone cancer	2.93e-05	0.000368	CbGpPWpGaD
Selegiline—CYP2A6—Metabolism—CYP3A4—bone cancer	2.91e-05	0.000366	CbGpPWpGaD
Selegiline—CYP2B6—Metabolism—DHFR—bone cancer	2.78e-05	0.000349	CbGpPWpGaD
Selegiline—CYP2E1—Metabolism—DHFR—bone cancer	2.72e-05	0.000342	CbGpPWpGaD
Selegiline—MAOB—Metabolism—PTGS2—bone cancer	2.65e-05	0.000333	CbGpPWpGaD
Selegiline—CYP2B6—Metabolism—GNA11—bone cancer	2.59e-05	0.000326	CbGpPWpGaD
Selegiline—CYP2E1—Metabolism—GNA11—bone cancer	2.54e-05	0.000319	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—ENO2—bone cancer	2.53e-05	0.000318	CbGpPWpGaD
Selegiline—CYP2A6—Metabolism—GSTP1—bone cancer	2.49e-05	0.000313	CbGpPWpGaD
Selegiline—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—bone cancer	2.46e-05	0.000309	CbGpPWpGaD
Selegiline—CYP2B6—Metabolism—CYP3A4—bone cancer	2.35e-05	0.000296	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—DHFR—bone cancer	2.35e-05	0.000295	CbGpPWpGaD
Selegiline—CYP2E1—Metabolism—CYP3A4—bone cancer	2.3e-05	0.00029	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—ENO2—bone cancer	2.26e-05	0.000284	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—ENO2—bone cancer	2.21e-05	0.000277	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—GNA11—bone cancer	2.2e-05	0.000276	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—DHFR—bone cancer	2.1e-05	0.000264	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—ENO2—bone cancer	2.08e-05	0.000261	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—ENO2—bone cancer	2.06e-05	0.000259	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—DHFR—bone cancer	2.05e-05	0.000257	CbGpPWpGaD
Selegiline—CYP2B6—Metabolism—GSTP1—bone cancer	2.01e-05	0.000253	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—CYP3A4—bone cancer	1.99e-05	0.00025	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.98e-05	0.000249	CbGpPWpGaD
Selegiline—CYP2E1—Metabolism—GSTP1—bone cancer	1.97e-05	0.000248	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—GNA11—bone cancer	1.96e-05	0.000246	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—DHFR—bone cancer	1.93e-05	0.000242	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—GNA11—bone cancer	1.91e-05	0.00024	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—DHFR—bone cancer	1.91e-05	0.00024	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—GNA11—bone cancer	1.8e-05	0.000227	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—GNA11—bone cancer	1.79e-05	0.000225	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—CYP3A4—bone cancer	1.78e-05	0.000223	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.77e-05	0.000222	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—ENO2—bone cancer	1.76e-05	0.000221	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—CYP3A4—bone cancer	1.73e-05	0.000218	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—GSTP1—bone cancer	1.7e-05	0.000214	CbGpPWpGaD
Selegiline—MAOA—Metabolism—PTGS2—bone cancer	1.66e-05	0.000209	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—CYP3A4—bone cancer	1.63e-05	0.000205	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—DHFR—bone cancer	1.63e-05	0.000205	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—CYP3A4—bone cancer	1.62e-05	0.000204	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.61e-05	0.000203	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—GNA11—bone cancer	1.53e-05	0.000192	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—GSTP1—bone cancer	1.52e-05	0.000191	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—GSTP1—bone cancer	1.48e-05	0.000186	CbGpPWpGaD
Selegiline—Benzyl alcohol—CYP3A4—bone cancer	1.45e-05	0.388	CrCbGaD
Selegiline—CYP2D6—Metabolism—GSTP1—bone cancer	1.4e-05	0.000176	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—GSTP1—bone cancer	1.39e-05	0.000174	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—CYP3A4—bone cancer	1.38e-05	0.000174	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.38e-05	0.000173	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—ENO2—bone cancer	1.36e-05	0.000171	CbGpPWpGaD
Selegiline—CYP2A6—Metabolism—PTGS2—bone cancer	1.29e-05	0.000162	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—DHFR—bone cancer	1.26e-05	0.000159	CbGpPWpGaD
Selegiline—Phenelzine—CYP3A4—bone cancer	1.23e-05	0.328	CrCbGaD
Selegiline—CYP1A2—Metabolism—GSTP1—bone cancer	1.18e-05	0.000149	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—GNA11—bone cancer	1.18e-05	0.000148	CbGpPWpGaD
Selegiline—Benzphetamine—CYP3A4—bone cancer	1.06e-05	0.284	CrCbGaD
Selegiline—CYP2B6—Metabolism—PTGS2—bone cancer	1.04e-05	0.000131	CbGpPWpGaD
Selegiline—CYP2E1—Metabolism—PTGS2—bone cancer	1.02e-05	0.000128	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—GSTP1—bone cancer	9.14e-06	0.000115	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—PTGS2—bone cancer	8.82e-06	0.000111	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—PTGS2—bone cancer	7.87e-06	9.9e-05	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—PTGS2—bone cancer	7.69e-06	9.66e-05	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—PTGS2—bone cancer	7.24e-06	9.1e-05	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—PTGS2—bone cancer	7.18e-06	9.02e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—PTGS2—bone cancer	6.14e-06	7.71e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—PTGS2—bone cancer	4.74e-06	5.95e-05	CbGpPWpGaD
